OUP user menu

Contractile and electrophysiological responses to progressive digitalis toxicity

V. S. BANKA, B. J. SCHERLAG, R. H. HELFANT
DOI: http://dx.doi.org/10.1093/cvr/9.1.65 65-72 First published online: 1 January 1975

AUTHORS' SYNOPSIS

Contractile force and intraventricular conduction during progressive ouabain infusion were examined in 15 dogs using a Walton-Brodie strain gauge arch and sequential atrial and bundle of His pacing. This permitted: (1) contractile force determination; (2) overdrive of arrhythmias; (3) maintenance of normal contraction sequences; (4) 'normal' ventricular depolarization; (5) rate control; (6) conduction measurements of the H-V interval (His-Purkinje conduction), QRS (intramyocardial conduction), and H-S interval (total intraventricular conduction).

Contractile force increased 21.2±4.3% at the onset of toxicity. After toxicity, there was a significant further increase (P < 0.01) to 50.1 f 12.4%. However, immediately before ventricular fibrillation, a 43.8 ± 8.2% decrease occurred (P < 0.01). H-V time showed no change (from 30 ± 2.7 to 31.5 ± 2.4 ms) at the onset of toxicity but after toxicity, it lengthened to 40.5 ± 3.1 ms (P < 0.05). QRS did show significant prolongation (69.5% ± 5.3 to 79.5 ± 6.9 ms; P < 0.05) at the onset of toxicity, but this was more marked (79.5 ± 6.9 to 130.5 ± 8.1 ms; P<0.01) after toxicity. H-S time was significantly prolonged (99.5 ± 6.2 to 111.0 ± 8.9 ms) before (P < 0.02) and after (P < 0.01) toxicity (111.O ± 8.9 to 171.1 ± 10.6 ms).

During toxicity there is progressive increase in contractile force with continued ouabain infusion. Progressive prolongation of intramyocardial conduction occurs in nontoxic and toxic doses, but His-Purkinje conduction is prolonged only in supratoxic doses.

    Sign in

    ESC members click here if your subscription is as an ESC Congress delegete or via your membership link.  Discover if you are an ESC member here.
    Note: after sign in you will be redirected to the journal's home page. 'ESC member' will display at the top of the page to indicate you have full access rights for this session.

    Otherwise, if your subscription is via OUP, enter your OUP username and password, or select an alternative sign in option below.

    Log in through your institution